{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:16:06Z","timestamp":1788671766228,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011947","name":"Abbott Nutrition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.obpill.2026.100296","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:14:07Z","timestamp":1784128447000},"page":"100296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0990-5821","authenticated-orcid":false,"given":"Shashank R.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrish","family":"Mithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7293-8864","authenticated-orcid":false,"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna G.","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-5249","authenticated-orcid":false,"given":"Subhankar","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganapathi","family":"Bantwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6310-6844","authenticated-orcid":false,"given":"Bipin","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jothydev","family":"Kesavadev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan Dev","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2557-3932","authenticated-orcid":false,"given":"Manash P.","family":"Baruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Budhwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Thakor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1553-0586","authenticated-orcid":false,"given":"Sachin","family":"Shende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2026.100296_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/19322968241291512","article-title":"Consensus report on glucagon-like peptide-1 receptor agonists as adjunctive treatment for individuals with type 1 diabetes using an automated insulin delivery system","volume":"19","author":"Shah","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.obpill.2026.100296_bib2","series-title":"MAGICapp - making GRADE the irresistible choice - guidelines and recommendations","year":"2025"},{"key":"10.1016\/j.obpill.2026.100296_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/dci24-0091","article-title":"Compounded GLP-1 and dual GIP\/GLP-1 receptor agonists: a statement from the American diabetes association","volume":"48","author":"Neumiller","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2026.100296_bib4","series-title":"GLP-1 and GLP-1\/GIP RA consensus statement for phased implementation","article-title":"Consensus statement: national criteria for the prioritisation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and GLP-1 RA\/Glucose-Dependent insulinotropic polypeptide receptor agonists (GIP RAs) for the treatment of obesity in NHS Scotland","year":"2024"},{"key":"10.1016\/j.obpill.2026.100296_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jacc.2025.05.024","article-title":"Concise clinical guidance: an ACC expert consensus statement on medical weight management for optimization of cardiovascular health","volume":"86","author":"Gilbert","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.obpill.2026.100296_bib6","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.3390\/nu17233735","article-title":"Beyond weight loss: GLP-1 usage and appetite regulation in the context of eating disorders and psychosocial processes","volume":"17","author":"Krug","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2026.100296_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/cimb47100787","article-title":"Obesity as a multifactorial chronic disease: molecular mechanisms, systemic impact, and emerging digital interventions","volume":"47","author":"M\u0142ynarska","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.obpill.2026.100296_bib8","article-title":"Optimizing GLP-1 therapies for obesity and diabetes management","volume":"16","author":"Noronha","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2026.100296_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/cob.70070","article-title":"Micronutrient and nutritional deficiencies associated with GLP-1 receptor agonist therapy: a narrative review","volume":"16","author":"Urbina","year":"2026","journal-title":"Clin Obes"},{"key":"10.1016\/j.obpill.2026.100296_bib10","article-title":"Dietary intake by patients taking GLP-1 and dual GIP\/GLP-1 receptor agonists: a narrative review and discussion of research needs","volume":"11","author":"Christensen","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2026.100296_bib11","article-title":"Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: a retrospective observational study","volume":"15","author":"Scott Butsch","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2026.100296_bib12","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.3390\/nu12092856","article-title":"Longitudinal observation of muscle mass over 10 Years according to serum calcium levels and calcium intake among Korean adults aged 50 and older: the Korean genome and epidemiology study","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2026.100296_bib13","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3390\/nu10121876","article-title":"Body composition changes in weight loss: strategies and supplementation for maintaining lean body mass, a brief review","volume":"10","author":"Willoughby","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2026.100296_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/nu17132073","article-title":"Influence of dietary calcium intake on skeletal health and body composition in an Italian elderly population","volume":"17","author":"Caffarelli","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2026.100296_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41430-021-01067-1","article-title":"Heterogeneity of Dietary practices in India: current status and implications for the prevention and control of type 2 diabetes","volume":"77","author":"Sachdev","year":"2023","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/ijph.2025.1607931","article-title":"A comparative study on the consumption patterns of processed food among individuals with and without type 2 diabetes","volume":"70","author":"Mahajan","year":"2025","journal-title":"Int J Publ Health"},{"key":"10.1016\/j.obpill.2026.100296_bib17","doi-asserted-by":"crossref","DOI":"10.1017\/jns.2021.102","article-title":"Micronutrient's deficiency in India: a systematic review and meta-analysis","volume":"10","author":"Venkatesh","year":"2021","journal-title":"J Nutr Sci"},{"key":"10.1016\/j.obpill.2026.100296_bib18","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1038\/s41591-025-03949-4","article-title":"Dietary profiles and associated metabolic risk factors in India from the ICMR\u2013INDIAB survey-21","volume":"31","author":"Anjana","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.obpill.2026.100296_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/JSHD.JSHD_38_17","article-title":"The sweet \u2018truth\u2019 of Gujarat \u2013 Gujarati diet & lifestyle and diabetogenesis","volume":"6","author":"Lakhani","year":"2018","journal-title":"J Soc Health Diabet"},{"key":"10.1016\/j.obpill.2026.100296_bib20","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3390\/ijms18102187","article-title":"Nutritional and acquired deficiencies in inositol bioavailability. Correlations with metabolic disorders","volume":"18","author":"Dinicola","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.obpill.2026.100296_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1753-4887.2011.00411.x","article-title":"Incorporation of whole, ancient grains into a modern Asian Indian diet: practical strategies to reduce the burden of chronic disease","volume":"69","author":"Dixit","year":"2011","journal-title":"Nutr Rev"},{"key":"10.1016\/j.obpill.2026.100296_bib22","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1017\/S1368980023002112","article-title":"Intake of ultra-processed food, dietary diversity and the risk of nutritional inadequacy among adults in India","volume":"26","author":"Mediratta","year":"2023","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu14245295","article-title":"The risk of sarcopenia among adults with normal-weight obesity in a nutritional management setting","volume":"14","author":"Lorenzo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2026.100296_bib24","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2147\/IJGM.S510412","article-title":"An Indian consensus on sarcopenia: epidemiology, etiology, clinical impact, screening, and therapeutic approaches","volume":"18","author":"Kalra","year":"2025","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.obpill.2026.100296_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005138","article-title":"Results from a dietary survey in an Indian T2DM population: a STARCH study","volume":"4","author":"Joshi","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.obpill.2026.100296_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41366-025-01952-w","article-title":"Bridging the nutrition guidance gap for GLP-1 receptor agonist therapy assisted weight loss: lessons from bariatric surgery","volume":"50","author":"Spreckley","year":"2026","journal-title":"Int J Obes"},{"key":"10.1016\/j.obpill.2026.100296_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000384","article-title":"Structured lifestyle intervention based on a trans-cultural diabetes-specific nutrition algorithm (tDNA) in individuals with type 2 diabetes: a randomized controlled trial","volume":"5","author":"Chee","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.obpill.2026.100296_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.899393","article-title":"The transcultural diabetes nutrition algorithm: a middle eastern version","volume":"9","author":"Hamdy","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med"},{"key":"10.1016\/j.obpill.2026.100296_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1507836","article-title":"Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment","volume":"15","author":"Lee","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.obpill.2026.100296_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.obpill.2026.100296_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.obpill.2026.100296_bib34","article-title":"Mechanism and context: making sense of adverse events with GLP-1-based therapy","volume":"4","author":"Hagelqvist","year":"2025","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.obpill.2026.100296_bib35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajcnut.2025.04.023","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American college of lifestyle medicine, the American society for nutrition, the obesity medicine association, and the obesity society","volume":"122","author":"Mozaffarian","year":"2025","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4093\/dmj.2025.0242","article-title":"Exploring the side effects of GLP-1 receptor agonist: to ensure its optimal positioning","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194740","article-title":"The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications","volume":"136","author":"Jalleh","year":"2026","journal-title":"J Clin Investig"},{"key":"10.1016\/j.obpill.2026.100296_bib38","article-title":"Adverse effects of GLP-1 receptor agonists: clinical Implications, regulatory perspectives, and future directions","volume":"61","author":"Abdelrahman","year":"2026","journal-title":"Obes Med"},{"key":"10.1016\/j.obpill.2026.100296_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151800","article-title":"A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia","volume":"131","author":"Winzeler","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.obpill.2026.100296_bib40","article-title":"Application of nutrition interventions with GLP-1 based therapies: a narrative review of the challenges and solutions","volume":"16","author":"Fitch","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2026.100296_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1032199","article-title":"Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data","volume":"13","author":"Dong","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.obpill.2026.100296_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46960-9","article-title":"Ancient origins of low lean mass among South Asians and implications for modern type 2 diabetes susceptibility","volume":"9","author":"Pomeroy","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.obpill.2026.100296_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41366-025-01934-y","article-title":"Visceral-to-peripheral adiposity ratio in proneness to sarcopenic obesity: association with low muscle strength, but not low muscle mass, in young women of South Asian descent","volume":"50","author":"Dulloo","year":"2026","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.obpill.2026.100296_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2025.103185","article-title":"Possible sarcopenia, sarcopenic obesity phenotypes and their association with diabetes: evidence from LASI wave-1 (2017-18)","volume":"19","author":"Kaur","year":"2025","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.obpill.2026.100296_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-026-01254-9","article-title":"Causes of sarcopenia and frailty in people taking GLP1RAs","author":"Langer","year":"2026","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.obpill.2026.100296_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/dom.16012","article-title":"Characterizing body composition modifying effects of a glucagon\u2010like peptide 1 receptor\u2010based agonist: a meta\u2010analysis","volume":"27","author":"Jiao","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.obpill.2026.100296_bib48","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.2147\/DDDT.S531778","article-title":"Semaglutide therapy and accelerated sarcopenia in older adults with type 2 diabetes: a 24-month retrospective cohort study","volume":"19","author":"Ren","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.obpill.2026.100296_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/dom.70141","article-title":"Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: the SEMALEAN study","volume":"28","author":"Alissou","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib51","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/dom.70242","article-title":"Semaglutide beyond weight loss: mechanistic insights and functional paradoxes from the SEMALEAN study","volume":"28","author":"Samajdar","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib52","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1210\/jendso\/bvab048.030","article-title":"Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study","volume":"5","author":"Wilding","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.obpill.2026.100296_bib53","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.3390\/jcm14155434","article-title":"Once-Weekly semaglutide improves body composition in Spanish obese adults with type 2 diabetes: a 48-week prospective real-life study","volume":"14","author":"Caballero-Mateos","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.obpill.2026.100296_bib54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00125-019-05065-8","article-title":"Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial","volume":"63","author":"McCrimmon","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.obpill.2026.100296_bib55","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once\u2010weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib56","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT\u20101 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102624","article-title":"Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial","volume":"72","author":"Hansen","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.obpill.2026.100296_bib58","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgag052","article-title":"Skeletal effect of semaglutide and tirzepatide in patients with increased risk of fractures","author":"Liu","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.aed.2025.10.001","article-title":"Comparison of fracture risk following semaglutide treatment vs sleeve gastrectomy","volume":"12","author":"Nore\u00f1a","year":"2025","journal-title":"AACE Endocrinol Diabetes"},{"key":"10.1016\/j.obpill.2026.100296_bib60","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1111\/dom.16541","article-title":"The effects of anti-obesity medications on bone metabolism: a critical appraisal","volume":"27","author":"Anastasilakis","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib61","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib62","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.3390\/jcm14113791","article-title":"Weight regain after liraglutide, semaglutide or tirzepatide interruption: a narrative review of randomized studies","volume":"14","author":"Quarenghi","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.obpill.2026.100296_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103796","article-title":"Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression","volume":"93","author":"Budini","year":"2026","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.obpill.2026.100296_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103680","article-title":"Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis","volume":"90","author":"Tzang","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.obpill.2026.100296_bib65","series-title":"Less than two years after stopping obesity drugs, weight and health issues return, study finds","year":"2026"},{"key":"10.1016\/j.obpill.2026.100296_bib66","article-title":"Rebound or retention: a meta-analysis of weight regain after the discontinuation of glucagon-like peptide-1 (GLP-1) receptor agonists and other anti-obesity drugs","volume":"17","author":"Kolli","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.obpill.2026.100296_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2026.100296_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jamainternmed.2025.6112","article-title":"Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity","volume":"186","author":"Horn","year":"2026","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.obpill.2026.100296_bib69","series-title":"Dietary guidelines for Indians-2024. Revised edition 2024; ICMR-national institute of nutrition: Tarnaka, Hyderabad-500 007, Telangana state, India","year":"2024"},{"key":"10.1016\/j.obpill.2026.100296_bib70","series-title":"Nutrition recommendations for patients on weight loss drugs. Capstone","author":"Duque","year":"2024"},{"key":"10.1016\/j.obpill.2026.100296_bib71","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clnu.2014.04.007","article-title":"Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group","volume":"33","author":"Deutz","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib72","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/nutrit\/nuv065","article-title":"Effects of dietary protein intake on body composition changes after weight loss in older adults: a systematic review and meta-analysis","volume":"74","author":"Kim","year":"2016","journal-title":"Nutr Rev"},{"key":"10.1016\/j.obpill.2026.100296_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000528083","article-title":"European association for the study of obesity position statement on medical nutrition therapy for the management of overweight and obesity in adults developed in collaboration with the European federation of the associations of dietitians","volume":"16","author":"Hassapidou","year":"2023","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2026.100296_bib74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2026.100296_bib75","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3945\/jn.116.243980","article-title":"Dietary protein and the health-nutrition-agriculture connection in India","volume":"147","author":"Minocha","year":"2017","journal-title":"J Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib76","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000220823","article-title":"Foods with a high fat quality are essential for healthy diets","volume":"54","author":"Zevenbergen","year":"2009","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1346869","article-title":"The nutrition and therapeutic potential of millets: an updated narrative review","volume":"11","author":"Jacob","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib78","first-page":"1","article-title":"RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2022","volume":"42","year":"2022","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/j.obpill.2026.100296_bib79","first-page":"S86","article-title":"5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes\u20142025","volume":"48","author":"Bajaj","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2026.100296_bib80","article-title":"Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: a narrative review","volume":"16","author":"Johnson","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2026.100296_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/bmjnph-2024-000950","article-title":"Burden of micronutrient deficiency among patients with type 2 diabetes: systematic review and meta-analysis","volume":"8","author":"Mangal","year":"2025","journal-title":"BMJ Nutr Prev Health"},{"key":"10.1016\/j.obpill.2026.100296_bib82","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00592-018-1240-x","article-title":"Prevalence of vitamin B12 deficiency in South Indians with different grades of glucose tolerance","volume":"55","author":"Jayashri","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.obpill.2026.100296_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114520001129","article-title":"Prevalence of vitamin D deficiency in urban south Indians with different grades of glucose tolerance","volume":"124","author":"Jayashri","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2024.08.001","article-title":"Understanding the additional impact of prediabetes and type 2 diabetes mellitus on vitamin C requirements in people living with obesity","volume":"130","author":"Carr","year":"2024","journal-title":"Nutr Res"},{"key":"10.1016\/j.obpill.2026.100296_bib85","article-title":"The impact of zinc supplementation on hyperglycemia and complications of type 2 diabetes mellitus","volume":"16","author":"Mehta","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.obpill.2026.100296_bib86","first-page":"13","article-title":"The effect of chromium supplements on insulin resistance: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Fatahi","year":"2025","journal-title":"J Health Med Sci"},{"key":"10.1016\/j.obpill.2026.100296_bib87","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.clnu.2018.06.957","article-title":"Effects of inositol on glucose homeostasis: systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Mi\u00f1ambres","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1400580","article-title":"Diabetes-specific formula with standard of care improves glycemic control, body composition, and cardiometabolic risk factors in overweight and obese adults with type 2 diabetes: results from a randomized controlled trial","volume":"11","author":"Tey","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib89","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.4103\/jfmpc.jfmpc_2395_20","article-title":"An observational study to estimate the level of essential trace elements and its implications in type 2 diabetes mellitus patients","volume":"10","author":"Sonkar","year":"2021","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.obpill.2026.100296_bib90","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/obr.12816","article-title":"A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss","volume":"20","author":"Astbury","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2026.100296_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-2891-6-12","article-title":"Nutrient adequacy during weight loss interventions: a randomized study in women comparing the dietary intake in a meal replacement group with a traditional food group","volume":"6","author":"Ashley","year":"2007","journal-title":"Nutr J"},{"key":"10.1016\/j.obpill.2026.100296_bib92","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/clinem\/dgz140","article-title":"GLP-1 analog modulates appetite, taste preference, gut hormones, and regional body fat stores in adults with obesity","volume":"105","author":"Kadouh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib93","article-title":"Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials","volume":"374","author":"Chiavaroli","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.obpill.2026.100296_bib94","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/diabetology7020024","article-title":"Clinical practice guide for integrating diabetes-specific nutritional formulas into diabetes care: evidence review and expert consensus","volume":"7","author":"Lin","year":"2026","journal-title":"Diabetology"},{"key":"10.1016\/j.obpill.2026.100296_bib95","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.clnu.2020.02.036","article-title":"Diabetes-specific formulas high in monounsaturated fatty acids and metabolic outcomes in patients with diabetes or hyperglycaemia. A systematic review and meta-analysis","volume":"39","author":"Sanz-Par\u00eds","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.obpill.2026.100296_bib96","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1111\/dom.16446","article-title":"Efficacy of diabetes-specific partial meal replacement on glycemic and weight control in type 2 diabetes: a randomized controlled trial","volume":"27","author":"Chen","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.obpill.2026.100296_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1636806","article-title":"Clinicians' view on non-adherence: sharing expert opinion","volume":"16","author":"Tan","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.obpill.2026.100296_bib98","series-title":"Nutritional assessment. In StatPearls [internet]","author":"Kesari","year":"2026"},{"key":"10.1016\/j.obpill.2026.100296_bib99","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ecl.2024.10.006","article-title":"Nutrient-stimulating hormone-based therapies for obesity","volume":"54","author":"Cristancho","year":"2025","journal-title":"Endocrinol Metab Clin North Am"}],"updated-by":[{"DOI":"10.1016\/j.obpill.2026.100314","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000}},{"DOI":"10.1016\/j.obpill.2026.100314","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:50:46Z","timestamp":1788670246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":98,"alternative-id":["S2667368126000525"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100296","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100296"}}